Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.

Yeo J, Morales DA, Chen T, Crawford EL, Zhang X, Blomquist TM, Levin AM, Massion PP, Arenberg DA, Midthun DE, Mazzone PJ, Nathan SD, Wainz RJ, Nana-Sinkam P, Willey PFS, Arend TJ, Padda K, Qiu S, Federov A, Hernandez DR, Hammersley JR, Yoon Y, Safi F, Khuder SA, Willey JC.

BMC Pulm Med. 2018 Mar 5;18(1):42. doi: 10.1186/s12890-018-0603-y.

2.

"Quick, Where Is My Cigarette?": Mining Tobacco History for More Information on Risk.

Arenberg D.

J Thorac Oncol. 2017 Nov;12(11):1606-1607. doi: 10.1016/j.jtho.2017.09.090. No abstract available.

PMID:
29074206
3.

Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.

Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, Wiener RS; ATS Assembly on Thoracic Oncology.

Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.

PMID:
28960111
4.

Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J.

J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468.

PMID:
27799513
5.

Indeterminate Pulmonary Nodules: How to Minimize Harm.

Barjaktarevic I, Arenberg D, Grimes BS, Ruchalski K, Aberle DR.

Semin Respir Crit Care Med. 2016 Oct;37(5):689-707. Epub 2016 Oct 12. Review.

PMID:
27732991
6.

Lung Cancer: Evolving Concepts in Management.

Arenberg D, Dubinett SM.

Semin Respir Crit Care Med. 2016 Oct;37(5):647-648. Epub 2016 Oct 12. No abstract available.

PMID:
27732986
7.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):651-65. doi: 10.1016/j.jtho.2016.01.025. Epub 2016 Mar 2.

8.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):681-92. doi: 10.1016/j.jtho.2015.12.114. Epub 2016 Mar 3.

9.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):639-50. doi: 10.1016/j.jtho.2016.01.024. Epub 2016 Mar 3.

10.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):666-80. doi: 10.1016/j.jtho.2015.12.113. Epub 2016 Mar 3.

11.

Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.

Crawford EL, Levin A, Safi F, Lu M, Baugh A, Zhang X, Yeo J, Khuder SA, Boulos AM, Nana-Sinkam P, Massion PP, Arenberg DA, Midthun D, Mazzone PJ, Nathan SD, Wainz R, Silvestri G, Tita J, Willey JC.

BMC Pulm Med. 2016 Jan 22;16:16. doi: 10.1186/s12890-016-0178-4.

12.

Evaluation of a Personalized, Web-Based Decision Aid for Lung Cancer Screening.

Lau YK, Caverly TJ, Cao P, Cherng ST, West M, Gaber C, Arenberg D, Meza R.

Am J Prev Med. 2015 Dec;49(6):e125-9. doi: 10.1016/j.amepre.2015.07.027. Epub 2015 Oct 9.

13.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

14.

Searching for red shirts. Emphysema as a lung cancer screening criterion?

Arenberg D.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):868-9. doi: 10.1164/rccm.201502-0381ED. No abstract available.

PMID:
25876199
15.

Competing mortality in cancer screening: a teachable moment.

Schneider D, Arenberg D.

JAMA Intern Med. 2015 Jun;175(6):896-7. doi: 10.1001/jamainternmed.2015.1232. No abstract available.

PMID:
25844567
16.

Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol.

Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg D, Meza R.

JMIR Res Protoc. 2014 Dec 19;3(4):e78. doi: 10.2196/resprot.4039.

17.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

18.

Emerging science and therapies in non-small-cell lung cancer: targeting the MET pathway.

Kris MG, Arenberg DA, Herbst RS, Riely GJ.

Clin Lung Cancer. 2014 Nov;15(6):475. doi: 10.1016/j.cllc.2014.08.001.

PMID:
25306384
19.

Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.

Freeman CM, Stolberg VR, Crudgington S, Martinez FJ, Han MK, Chensue SW, Arenberg DA, Meldrum CA, McCloskey L, Curtis JL.

PLoS One. 2014 Jul 31;9(7):e103840. doi: 10.1371/journal.pone.0103840. eCollection 2014.

20.

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.

Freeman CM, McCubbrey AL, Crudgington S, Nelson J, Martinez FJ, Han MK, Washko GR Jr, Chensue SW, Arenberg DA, Meldrum CA, McCloskey L, Curtis JL.

PLoS One. 2014 May 7;9(5):e96421. doi: 10.1371/journal.pone.0096421. eCollection 2014.

21.

Quality indicators for the evaluation of patients with lung cancer.

Mazzone PJ, Vachani A, Chang A, Detterbeck F, Cooke D, Howington J, Dodi A, Arenberg D.

Chest. 2014 Sep;146(3):659-669. doi: 10.1378/chest.13-2900.

22.

Nodule volume measurement: pushing the pendulum.

Arenberg DA.

Chest. 2014 Mar 1;145(3):440-2. doi: 10.1378/chest.13-1964. No abstract available.

PMID:
24590013
23.

Nodule Volume Measurement.

Arenberg DA.

Chest. 2014 Mar;145(3):440-442. doi: 10.1378/chest.13-1964. No abstract available.

PMID:
27845627
24.

Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging.

Kinsey CM, Arenberg DA.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):640-9. doi: 10.1164/rccm.201311-2007CI. Review.

PMID:
24484269
25.

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series).

Quint LE, Reddy RM, Lin J, Arenberg DA, Speers C, Hayman JA, Kong FP, Orringer MB, Kalemkerian GP.

Cancer Imaging. 2013 Dec 6;13(3):429-39. doi: 10.1102/1470-7330.2013.0037.

26.

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series).

Quint LE, Reddy RM, Lin J, Arenberg DA, Speers C, Hayman JA, Kong FP, Orringer MB, Kalemkerian GP.

Cancer Imaging. 2013 Dec 6;13(3):440-7. doi: 10.1102/1470-7330.2013.0030.

27.

Lung cancer screening.

Arenberg D.

Semin Respir Crit Care Med. 2013 Dec;34(6):727-37. doi: 10.1055/s-0033-1358549. Epub 2013 Nov 20. Review.

PMID:
24258563
28.

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA, Diekemper R, Detterbeck FC, Arenberg DA.

Chest. 2013 May;143(5 Suppl):e314S-e340S. doi: 10.1378/chest.12-2360.

PMID:
23649445
29.

Lung CD8+ T cells in COPD have increased expression of bacterial TLRs.

Freeman CM, Martinez FJ, Han MK, Washko GR Jr, McCubbrey AL, Chensue SW, Arenberg DA, Meldrum CA, McCloskey L, Curtis JL.

Respir Res. 2013 Feb 1;14:13. doi: 10.1186/1465-9921-14-13.

30.

Endobronchial biopsy of an intrapulmonary arterial mass.

Horowitz JC, Kleaveland K, Arenberg D.

J Bronchology Interv Pulmonol. 2013 Jan;20(1):93-5. doi: 10.1097/LBR.0b013e3182814b02.

PMID:
23328154
31.

Lung cancer: multidisciplinary approach to tissue sampling.

Chang AC, Sundaram B, Arenberg DA.

Radiol Clin North Am. 2012 Sep;50(5):951-60. doi: 10.1016/j.rcl.2012.05.001. Review.

PMID:
22974780
32.

Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.

Wang J, Cao J, Yuan S, Ji W, Arenberg D, Dai J, Stanton P, Tatro D, Ten Haken RK, Wang L, Kong FM.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):798-804. doi: 10.1016/j.ijrobp.2012.06.040. Epub 2012 Jul 24.

33.

Setting up a lung cancer screening program.

Arenberg D, Kazerooni EA.

J Natl Compr Canc Netw. 2012 Feb;10(2):277-85. Review.

PMID:
22308520
34.

Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.

Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e631-8. doi: 10.1016/j.ijrobp.2011.07.044. Epub 2011 Dec 22.

35.

The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma.

Betz BL, Roh MH, Weigelin HC, Placido JB, Schmidt LA, Farmen S, Arenberg DA, Kalemkerian GP, Knoepp SM.

Am J Clin Pathol. 2011 Oct;136(4):564-71. doi: 10.1309/AJCP84TUTQOSUONG.

PMID:
21917678
36.

Prognostic implications of parathyroid hormone-related protein in males and females with non--small-cell lung cancer.

Montgrain PR, Deftos LJ, Arenberg D, Tipps A, Quintana R, Carskadon S, Hastings RH.

Clin Lung Cancer. 2011 May;12(3):197-205. doi: 10.1016/j.cllc.2011.03.018. Epub 2011 Apr 24.

PMID:
21663864
37.

The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.

Roh MH, Schmidt L, Placido J, Farmen S, Fields KL, Courey AJ, Arenberg DA, Knoepp SM.

Diagn Cytopathol. 2012 Nov;40(11):949-55. doi: 10.1002/dc.21680. Epub 2011 Apr 15.

38.

Bronchioloalveolar carcinoma.

Arenberg D.

Semin Respir Crit Care Med. 2011 Feb;32(1):52-61. doi: 10.1055/s-0031-1272869. Epub 2011 Apr 15. Review.

PMID:
21500124
39.

Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning.

Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Curtis JL, Cai XW, Ramnath N, Kalemkerian GP, Ten Haken RK, Eisbruch A, Kong FM.

J Thorac Oncol. 2011 Jan;6(1):71-8. doi: 10.1097/JTO.0b013e3181f77b40.

40.

Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.

Arenberg D, Luckhardt TR, Carskadon S, Zhao L, Amin MA, Koch AE.

Am J Respir Crit Care Med. 2010 Oct 15;182(8):1030-7. doi: 10.1164/rccm.201001-0120OC. Epub 2010 Jun 25.

41.

Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.

Freeman CM, Han MK, Martinez FJ, Murray S, Liu LX, Chensue SW, Polak TJ, Sonstein J, Todt JC, Ames TM, Arenberg DA, Meldrum CA, Getty C, McCloskey L, Curtis JL.

J Immunol. 2010 Jun 1;184(11):6504-13. doi: 10.4049/jimmunol.1000006. Epub 2010 Apr 28.

42.

Multidisciplinary Evaluation of Patients With Suspected Lung Cancer.

Bauman K, Arenberg D.

Clin Pulm Med. 2010 Jan 1;17(1):35-41.

43.

PET scans for lung nodules: costs and cost-effectiveness.

Arenberg D.

Chest. 2010 Jan;137(1):4-6. doi: 10.1378/chest.09-1453. No abstract available.

PMID:
20051397
44.

Electromagnetic navigation guided bronchoscopy.

Arenberg D.

Cancer Imaging. 2009 Nov 6;9:89-95. doi: 10.1102/1470-7330.2009.0016. Review.

45.

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.

Freeman CM, Martinez FJ, Han MK, Ames TM, Chensue SW, Todt JC, Arenberg DA, Meldrum CA, Getty C, McCloskey L, Curtis JL.

Am J Respir Crit Care Med. 2009 Dec 15;180(12):1179-88. doi: 10.1164/rccm.200904-0552OC. Epub 2009 Sep 3.

46.

Time to treatment in patients with stage III non-small cell lung cancer.

Wang L, Correa CR, Hayman JA, Zhao L, Cease K, Brenner D, Arenberg D, Curtis J, Kalemkerian GP, Kong FM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):790-5. doi: 10.1016/j.ijrobp.2008.08.039. Epub 2009 Feb 21.

47.

Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ, Horowitz JC.

Am J Respir Cell Mol Biol. 2009 Oct;41(4):484-93. doi: 10.1165/rcmb.2008-0447OC. Epub 2009 Feb 2.

48.

Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.

McClelland M, Zhao L, Carskadon S, Arenberg D.

Am J Pathol. 2009 Feb;174(2):638-46. doi: 10.2353/ajpath.2009.080463. Epub 2009 Jan 8.

49.

Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Arenberg D; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):306S-13S.

PMID:
17873176
50.

The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.

Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM.

Lung Cancer. 2008 Feb;59(2):232-9. Epub 2007 Oct 1.

PMID:
17905467

Supplemental Content

Loading ...
Support Center